Climb Bio to Present at Upcoming September 2025 Investor Conferences

About this update from Climb Bio, Inc.

[{"type":"image","alt":"Climb Bio, Inc.","displaySize":"","headline":null,"caption":"Climb Bio, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":300,"url":"https://media.zenfs.com/en/globenewswire.com/96b5fbbb4dd8bc4bbccc298a6909629c"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/upR1wQHp9TCZxvAhULaG8g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTQyMDtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/96b5fbbb4dd8bc4bbccc298a6909629c","width":300,"height":300}},"lazy":false},{"type":"text","content":"WELLESLEY HILLS, Mass., Aug. 25, 2025 (GLOBE NEWSWIRE) -- Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company developing therapeutics for immune-mediated diseases, today announced that members of its executive team will participate in the upcoming investor conferences detailed below.","length":303,"tagName":"p"},{"type":"text","content":"Cantor Global Healthcare ConferenceLocation: New York, NYFormat: Fireside chat and one-on-one investor meetingsDate: Friday, September 5, 2025Time: 10:55 a.m. ET","length":165,"tagName":"p"},{"type":"text","content":"Baird Global Healthcare ConferenceLocation: New York, NYFormat: Fireside chat and one-on-one investor meetingsDate: Tuesday, September 9, 2025Time: 4:20 PM p.m. ET","length":167,"tagName":"p"},{"type":"text","content":"Morgan Stanley Annual Global Healthcare ConferenceLocation: New York, NYFormat: One-on-one meetings onlyDate: Wednesday, September 10, 2025","length":142,"tagName":"p"},{"type":"text","content":"Stifel Virtual Immunology and Inflammation ForumLocation: Virtual Format: Presentation and one-on-one investor meetingsDate: Wednesday, September 10, 2025Time: 10:30 a.m. ET","length":177,"tagName":"p"},{"type":"text","content":"The live webcasts will be accessible via the “Investors and News” section of the Climb Bio website: https://ir.climbbio.com/. Webcast replays will be available on the Climb Bio website beginning approximately two hours after each webcast event and will be archived for at least 30 days.","length":286,"tagName":"p"},{"type":"text","content":"About Climb Bio, Inc.Climb Bio, Inc. is a clinical-stage biotechnology company developing therapeutics for patients with immune-mediated diseases. The Company’s pipeline includes, budoprutug, an anti-CD19 monoclonal antibody that has demonstrated B-cell depletion and has potential to tr...

More updates from Climb Bio, Inc.